Stay updated on Ibrutinib and Nivolumab Trial in Hodgkin Lymphoma

Sign up to get notified when there's something new on the Ibrutinib and Nivolumab Trial in Hodgkin Lymphoma page.
Latest website image capture
Clouds background image

Latest updates to the Ibrutinib and Nivolumab Trial in Hodgkin Lymphoma page

  1. Check
    6 days ago
    Change Detected
    Summary
    Site revision history shows an addition of v3.5.0 and a deletion of v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T23:30:45.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T20:21:19.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The study record shows new update dates (2026-02-12, 2026-02-17, 2026-08-15) and the field 'Product Manufactured in and Exported from the U.S.' has been removed.
    Difference
    0.5%
    Check dated 2026-02-19T04:52:51.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.2, replacing the previous Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T02:23:50.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    Revision: v3.4.1 appears in the page footer, replacing v3.4.0; no other changes observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T22:54:45.000Z thumbnail image
  8. Check
    56 days ago
    Change Detected
    Summary
    Show glossary has been added to the page. Metadata/UI strings related to QC criteria updates and versioning were updated (e.g., 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'), including capitalization tweaks for 'No FEAR Act Data'.
    Difference
    0.2%
    Check dated 2026-01-28T21:26:41.000Z thumbnail image

Stay in the know with updates to Ibrutinib and Nivolumab Trial in Hodgkin Lymphoma

Enter your email address, and we'll notify you when there's something new on the Ibrutinib and Nivolumab Trial in Hodgkin Lymphoma page.